{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:19:47Z","timestamp":1793996387317,"version":"4.8.0"},"reference-count":178,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Metabolic-Associated Fatty Liver Disease (MAFLD) is the most common chronic liver disease worldwide, associated with systemic metabolic dysregulation. It can progress from simple hepatic steatosis (MAFL) to more severe conditions like Metabolic-Associated Steatohepatitis (MASH), fibrosis, cirrhosis, and Hepatocellular Carcinoma (HCC). There is a critical lack of reliable non-invasive diagnostic methods and effective pharmaceutical treatments for MAFLD\/MASH, emphasizing the need for further research. Extracellular vesicles (EVs) are nanoscale structures that play important roles in cell signaling by delivering bioactive molecules. However, there is a significant gap in literature regarding the roles of EVs from hosts, plants, and microbiota in MAFLD. This review explores the potential of EVs from various sources\u2014host, plants, and microbiota\u2014as biomarkers, therapeutic agents, drug carriers, and treatment targets for MAFLD. Firstly, the roles of host-derived extracellular vesicles (EVs) in MAFLD, with a focus on cell-type specific EVs and their components\u2014proteins, miRNAs, and lipids\u2014for disease diagnosis and monitoring were discussed. Moreover, it highlighted the therapeutic potential of mesenchymal stem cell (MSC)-derived EVs in reducing lipid accumulation and liver injury, and immune cell-derived EVs in mitigating inflammation and fibrosis. The review also discussed the use of host-derived EVs as drug carriers and therapeutic targets due to their ability to deliver bioactive molecules that impact disease mechanisms. Additionally, it summarized research on plant-derived EVs, which help reduce liver lipid accumulation, inflammation, and enhance gut barrier function in MAFLD. Also, the review explored microbial-derived EVs as novel therapeutic targets, particularly in relation to insulin resistance, liver inflammation, and dysfunction in MAFLD. Overall, by exploring the diverse roles of EVs from host, plant, and microbiota sources in MAFLD, this review offers valuable insights into their potential as non-invasive biomarkers and novel therapeutic strategies, which could pave the way for more effective diagnostic and treatment options for this increasingly prevalent liver disease. Notably, the challenges of translating EVs into clinical practice were also thoroughly discussed, aiming to provide possible directions and strategies for future research.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1544012","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T01:15:21Z","timestamp":1741569321000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Roles of extracellular vesicles from different origins in metabolic-associated fatty liver disease: progress and perspectives"],"prefix":"10.3389","volume":"16","author":[{"given":"Jing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuoqiang","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caihong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.18-3-245","article-title":"Non-alcoholic fatty liver disease","volume":"18","author":"Maurice","year":"2018","journal-title":"Clin Med (Lond)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.07.021","article-title":"Can we use old NAFLD data under the new MASLD definition","volume":"80","author":"Song","year":"2023","journal-title":"J Hepatol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.cgh.2014.04.014","article-title":"Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies","volume":"13","author":"Singh","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1210\/er.2019-00034","article-title":"The liver as an endocrine organ-linking NAFLD and insulin resistance","volume":"40","author":"Watt","year":"2019","journal-title":"Endocr Rev"},{"key":"B7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/annurev-physiol-021115-105331","article-title":"Pathophysiology and mechanisms of nonalcoholic fatty liver disease","volume":"78","author":"Haas","year":"2016","journal-title":"Annu Rev Physiol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-019-0144-8","article-title":"Past, present and future perspectives in nonalcoholic fatty liver disease","volume":"16","author":"Sanyal","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jhepr.2019.02.004","article-title":"Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism","volume":"1","author":"Lefere","year":"2019","journal-title":"JHEP Rep"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2013.149","article-title":"From NAFLD to NASH to cirrhosis-new insights into disease mechanisms","volume":"10","author":"Wree","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1053\/j.gastro.2010.07.057","article-title":"Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease","volume":"139","author":"Chalasani","year":"2010","journal-title":"Gastroenterology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41392-022-01119-3","article-title":"Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver\/steatohepatitis (NAFL\/NASH)","volume":"7","author":"Xu","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21155214","article-title":"Gut microbiota metabolites in NAFLD pathogenesis and therapeutic implications","volume":"21","author":"Chen","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1291501","article-title":"Metabolic-associated fatty liver disease: a selective review of pathogenesis, diagnostic approaches, and therapeutic strategies","volume":"11","author":"Habibullah","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.11.051","article-title":"AGA clinical practice update on lifestyle modification using diet and exercise to achieve weight loss in the management of nonalcoholic fatty liver disease: expert review","volume":"160","author":"Younossi","year":"2021","journal-title":"Gastroenterology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2023.1225946","article-title":"Mediterranean diet affects the metabolic outcome of metabolic dysfunction-associated fatty liver disease","volume":"10","author":"Xiao","year":"2023","journal-title":"Front Nutr"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2024.5412","article-title":"Current strategies for nonalcoholic fatty liver disease treatment (Review)","volume":"54","author":"Sun","year":"2024","journal-title":"Int J Mol Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-022-00711-5","article-title":"Metabolic mechanisms for and treatment of NAFLD or NASH occurring after liver transplantation","volume":"18","author":"Lonardo","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(21)00261-2","article-title":"Efficacy of peroxisome proliferator-activated receptor agonists, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors for treatment of non-alcoholic fatty liver disease: a systematic review","volume":"7","author":"Mantovani","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.622589","article-title":"Comparison of the efficacy of glucagon-like peptide-1 receptor agonists in patients with metabolic associated fatty liver disease: updated systematic review and meta-analysis","volume":"11","author":"Dai","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v10.i2.114","article-title":"SGLT-2 inhibitors in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus: A systematic review","volume":"10","author":"Raj","year":"2019","journal-title":"World J Diabetes"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-024-00747-9","article-title":"First US drug approved for a liver disease surging around the world","author":"Ledford","year":"2024","journal-title":"Nature"},{"key":"B26","doi-asserted-by":"publisher","first-page":"19790","DOI":"10.1038\/s41598-024-70242-8","article-title":"Efficacy and safety of Resmetirom, a selective thyroid hormone receptor-\u03b2 agonist, in the treatment of metabolic dysfunction-associated steatotic liver disease (MASLD): a systematic review and meta-analysis","volume":"14","author":"Suvarna","year":"2024","journal-title":"Sci Rep"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01652-8","article-title":"Non-invasive biomarkers of nonalcoholic steatohepatitis: the FNIH NIMBLE project","volume":"28","author":"Sanyal","year":"2022","journal-title":"Nat Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-018-0014-9","article-title":"Noninvasive biomarkers in NAFLD and NASH - current progress and future promise","volume":"15","author":"Wong","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"155721","DOI":"10.1016\/j.metabol.2023.155721","article-title":"Can liquid biopsies for MASH help increase the penetration of metabolic surgery? A narrative review","volume":"151","author":"Castagneto-Gissey","year":"2024","journal-title":"Metabolism"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/biom13091369","article-title":"The current status of the liver liquid biopsy in MASH related HCC: overview and future directions","volume":"13","author":"Ugonabo","year":"2023","journal-title":"Biomolecules"},{"key":"B31","doi-asserted-by":"publisher","first-page":"27066","DOI":"10.3402\/jev.v4.27066","article-title":"Biological properties of extracellular vesicles and their physiological functions","volume":"4","author":"Y\u00e1\u00f1ez-M\u00f3","year":"2015","journal-title":"J Extracell Vesicles"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.74137","article-title":"Role of extracellular vesicles in osteosarcoma","volume":"19","author":"Yang","year":"2022","journal-title":"Int J Med Sci"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-018-0049-8","article-title":"Size matters in nanoscale communication","volume":"20","author":"Zijlstra","year":"2018","journal-title":"Nat Cell Biol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-3512","article-title":"Cellular disposal of miR23b by RAB27-dependent exosome release is linked to acquisition of metastatic properties","volume":"74","author":"Ostenfeld","year":"2014","journal-title":"Cancer Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.101.3.942","article-title":"Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes","volume":"101","author":"Pan","year":"1985","journal-title":"J Cell Biol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-022-00460-3","article-title":"Challenges and directions in studying cell-cell communication by extracellular vesicles","volume":"23","author":"van Niel","year":"2022","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/cas.2016.107.issue-4","article-title":"Extracellular vesicle transfer of cancer pathogenic components","volume":"107","author":"Fujita","year":"2016","journal-title":"Cancer Sci"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e12151","DOI":"10.1002\/jev2.12151","article-title":"In sickness and in health: The functional role of extracellular vesicles in physiology and pathology in vivo: Part I: Health and Normal Physiology: Part I: Health and Normal Physiology","volume":"11","author":"Yates","year":"2022","journal-title":"J Extracell Vesicles"},{"key":"B39","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.tcb.2020.09.009","article-title":"Extracellular vesicle-associated proteins in tissue repair","volume":"30","author":"Roefs","year":"2020","journal-title":"Trends Cell Biol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e12190","DOI":"10.1002\/jev2.12190","article-title":"In sickness and in health: The functional role of extracellular vesicles in physiology and pathology in vivo: Part II: Pathology: Part II: Pathology","volume":"11","author":"Yates","year":"2022","journal-title":"J Extracell Vesicles"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9010093","article-title":"Extracellular vesicles as drivers of non-alcoholic fatty liver disease: small particles with big impact","volume":"9","author":"Ipsen","year":"2021","journal-title":"Biomedicines"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.04.027","article-title":"Separation, characterization, and standardization of extracellular vesicles for drug delivery applications","volume":"174","author":"Buschmann","year":"2021","journal-title":"Adv Drug Delivery Rev"},{"key":"B43","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41392-024-01735-1","article-title":"Extracellular vesicles as tools and targets in therapy for diseases","volume":"9","author":"Kumar","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e1835","DOI":"10.1002\/wnan.v15.1","article-title":"Isolation and characterization of extracellular vesicles and future directions in diagnosis and therapy","volume":"15","author":"De Sousa","year":"2023","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12951-023-01973-5","article-title":"Extracellular vesicles: a rising star for therapeutics and drug delivery","volume":"21","author":"Du","year":"2023","journal-title":"J Nanobiotechnology"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2017.71","article-title":"Extracellular vesicles in liver disease and potential as biomarkers and therapeutic targets","volume":"14","author":"Szabo","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28814","article-title":"Extracellular vesicles in liver pathobiology: Small particles with big impact","volume":"64","author":"Hirsova","year":"2016","journal-title":"Hepatology"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M063412","article-title":"Hepatocytes release ceramide-enriched pro-inflammatory extracellular vesicles in an IRE1\u03b1-dependent manner","volume":"57","author":"Kakazu","year":"2016","journal-title":"J Lipid Res"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1404","article-title":"Characterization of cellular sources and circulating levels of extracellular vesicles in a dietary murine model of nonalcoholic steatohepatitis","volume":"3","author":"Li","year":"2019","journal-title":"Hepatol Commun"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.04.031","article-title":"Circulating microparticles as disease-specific biomarkers of severity of inflammation in patients with hepatitis C or nonalcoholic steatohepatitis","volume":"143","author":"Kornek","year":"2012","journal-title":"Gastroenterology"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2016.11.003","article-title":"Extracellular vesicles: unique intercellular delivery vehicles","volume":"27","author":"Maas","year":"2017","journal-title":"Trends Cell Biol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201600756R","article-title":"Cargo proteins of plasma astrocyte-derived exosomes in Alzheimer's disease","volume":"30","author":"Goetzl","year":"2016","journal-title":"FASEB J"},{"key":"B53","doi-asserted-by":"publisher","first-page":"102430","DOI":"10.1016\/j.nano.2021.102430","article-title":"Circulating extracellular vesicles are a biomarker for NAFLD resolution and response to weight loss surgery","volume":"36","author":"Nakao","year":"2021","journal-title":"Nanomedicine"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.735001","article-title":"A comparative proteomic analysis of extracellular vesicles associated with lipotoxicity","volume":"9","author":"Nakao","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3390\/nu14061133","article-title":"Exosomal FZD-7 expression is modulated by different lifestyle interventions in patients with NAFLD","volume":"14","author":"Scavo","year":"2022","journal-title":"Nutrients"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15604","article-title":"Role of EpCAM+ CD133+ extracellular vesicles in steatosis to steatohepatitis transition in NAFLD","volume":"43","author":"Mu\u00f1oz-Hern\u00e1ndez","year":"2023","journal-title":"Liver Int"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1556","article-title":"Characterization and proteome of circulating extracellular vesicles as potential biomarkers for NASH","volume":"4","author":"Povero","year":"2020","journal-title":"Hepatol Commun"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-023-10520-1","article-title":"Exosome GLUT1 derived from hepatocyte identifies the risk of non-alcoholic steatohepatitis and fibrosis","volume":"17","author":"Zhang","year":"2023","journal-title":"Hepatol Int"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e113651","DOI":"10.1371\/journal.pone.0113651","article-title":"Circulating extracellular vesicles with specific proteome and liver microRNAs are potential biomarkers for liver injury in experimental fatty liver disease","volume":"9","author":"Povero","year":"2014","journal-title":"PloS One"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10010195","article-title":"Selective isolation of liver-derived extracellular vesicles redefines performance of miRNA biomarkers for non-alcoholic fatty liver disease","volume":"10","author":"Newman","year":"2022","journal-title":"Biomedicines"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.13304","article-title":"Impact of sodium glucose cotransporter 2 inhibitor on histological features and glucose metabolism of non-alcoholic fatty liver disease complicated by diabetes mellitus","volume":"49","author":"Akuta","year":"2019","journal-title":"Hepatol Res"},{"key":"B62","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3390\/cells12010169","article-title":"Exosomes from short-term high-fat or high-sucrose fed mice induce hepatic steatosis through different pathways","volume":"12","author":"Casta\u00f1o","year":"2022","journal-title":"Cells"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1007\/s13258-021-01150-8","article-title":"microRNA profiles of serum exosomes derived from children with nonalcoholic fatty liver","volume":"44","author":"Zhang","year":"2022","journal-title":"Genes Genomics"},{"key":"B64","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1159\/000506665","article-title":"Exosomal miRNAs profile in children's nonalcoholic fatty liver disease and the correlation with transaminase and uric acid","volume":"76","author":"Zhou","year":"2020","journal-title":"Ann Nutr Metab"},{"key":"B65","article-title":"Potential biomarkers in NASH-induced liver cirrhosis with hepatocellular carcinoma: A preliminary work on roles of exosomal miR-182, miR-301a, and miR-373","volume":"42","author":"Muhammad Yusuf","year":"2020","journal-title":"Malays J Pathol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1186\/s12951-022-01540-4","article-title":"Lipidomic identification of urinary extracellular vesicles for non-alcoholic steatohepatitis diagnosis","volume":"20","author":"Zhu","year":"2022","journal-title":"J Nanobiotechnology"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2018.03.011","article-title":"Stem cells: their source, potency and use in regenerative therapies with focus on adipose-derived stem cells - a review","volume":"36","author":"Bacakova","year":"2018","journal-title":"Biotechnol Adv"},{"key":"B68","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s13287-024-03885-z","article-title":"Translational potential of mesenchymal stem cells in regenerative therapies for human diseases: challenges and opportunities","volume":"15","author":"Zhidu","year":"2024","journal-title":"Stem Cell Res Ther"},{"key":"B69","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/s41392-022-01134-4","article-title":"Stem cell-based therapy for human diseases","volume":"7","author":"Hoang","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3390\/cells10020240","article-title":"The future of regenerative medicine: cell therapy using pluripotent stem cells and acellular therapies based on extracellular vesicles","volume":"10","author":"Jarrige","year":"2021","journal-title":"Cells"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1089\/ten.teb.2020.0222","article-title":"The emerging potential of extracellular vesicles in cell-free tissue engineering and regenerative medicine","volume":"27","author":"Alqurashi","year":"2021","journal-title":"Tissue Eng Part B Rev"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1007\/s13577-021-00593-1","article-title":"Human umbilical cord-derived mesenchymal stem cell-exosomal miR-627-5p ameliorates non-alcoholic fatty liver disease by repressing FTO expression","volume":"34","author":"Cheng","year":"2021","journal-title":"Hum Cell"},{"key":"B73","doi-asserted-by":"publisher","first-page":"100746","DOI":"10.1016\/j.jhepr.2023.100746","article-title":"Human umbilical cord mesenchymal stem cell-derived exosomes ameliorate liver steatosis by promoting fatty acid oxidation and reducing fatty acid synthesis","volume":"5","author":"Yang","year":"2023","journal-title":"JHEP Rep"},{"key":"B74","doi-asserted-by":"publisher","first-page":"18431","DOI":"10.1038\/s41598-023-45828-3","article-title":"Comparison of effects of HucMSCs, exosomes, and conditioned medium on NASH","volume":"13","author":"Liang","year":"2023","journal-title":"Sci Rep"},{"key":"B75","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.freeradbiomed.2022.08.037","article-title":"Exosomes derived from human umbilical cord mesenchymal stem cells ameliorate experimental non-alcoholic steatohepatitis via Nrf2\/NQO-1 pathway","volume":"192","author":"Kang","year":"2022","journal-title":"Free Radic Biol Med"},{"key":"B76","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1186\/s13287-022-03201-7","article-title":"Human umbilical cord mesenchymal stromal cell-derived exosomes protect against MCD-induced NASH in a mouse model","volume":"13","author":"Shi","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"B77","doi-asserted-by":"publisher","first-page":"3212643","DOI":"10.1155\/2018\/3212643","article-title":"Extracellular vesicles from amnion-derived mesenchymal stem cells ameliorate hepatic inflammation and fibrosis in rats","volume":"2018","author":"Ohara","year":"2018","journal-title":"Stem Cells Int"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24098092","article-title":"MSC-sEV treatment polarizes pro-fibrotic M2 macrophages without exacerbating liver fibrosis in NASH","volume":"24","author":"Zhang","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B79","doi-asserted-by":"publisher","first-page":"114624","DOI":"10.1016\/j.bcp.2021.114624","article-title":"Upregulation of miR-96-5p by bone marrow mesenchymal stem cells and their exosomes alleviate non-alcoholic steatohepatitis: Emphasis on caspase-2 signaling inhibition","volume":"190","author":"El-Derany","year":"2021","journal-title":"Biochem Pharmacol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.reth.2020.03.012","article-title":"Development of a non-alcoholic steatohepatitis model with rapid accumulation of fibrosis, and its treatment using mesenchymal stem cells and their small extracellular vesicles","volume":"14","author":"Watanabe","year":"2020","journal-title":"Regener Ther"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.2337\/db17-0356","article-title":"Exosomes from adipose-derived stem cells attenuate adipose inflammation and obesity through polarizing M2 macrophages and beiging in white adipose tissue","volume":"67","author":"Zhao","year":"2018","journal-title":"Diabetes"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2019.10.016","article-title":"HLSC-derived extracellular vesicles attenuate liver fibrosis and inflammation in a murine model of non-alcoholic steatohepatitis","volume":"28","author":"Bruno","year":"2020","journal-title":"Mol Ther"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1061485","article-title":"Therapeutic effects of CD133 + Exosomes on liver function after stroke in type 2 diabetic mice","volume":"17","author":"Venkat","year":"2023","journal-title":"Front Neurosci"},{"key":"B84","doi-asserted-by":"publisher","first-page":"104597","DOI":"10.1016\/j.isci.2022.104597","article-title":"M2 macrophage-derived exosomal microRNA-411-5p impedes the activation of hepatic stellate cells by targeting CAMSAP1 in NASH model","volume":"25","author":"Wan","year":"2022","journal-title":"iScience"},{"key":"B85","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.cmet.2022.05.008","article-title":"MiR-690 treatment causes decreased fibrosis and steatosis and restores specific Kupffer cell functions in NASH","volume":"34","author":"Gao","year":"2022","journal-title":"Cell Metab"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1172\/JCI141513","article-title":"Neutrophil-to-hepatocyte communication via LDLR-dependent miR-223-enriched extracellular vesicle transfer ameliorates nonalcoholic steatohepatitis","volume":"131","author":"He","year":"2021","journal-title":"J Clin Invest"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31658","article-title":"Myeloid-cell-specific IL-6 signaling promotes microRNA-223-enriched exosome production to attenuate NAFLD-associated fibrosis","volume":"74","author":"Hou","year":"2021","journal-title":"Hepatology"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.80122","article-title":"Myeloid-specific blockade of Notch signaling ameliorates nonalcoholic fatty liver disease in mice","volume":"19","author":"Ding","year":"2023","journal-title":"Int J Biol Sci"},{"key":"B89","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/s12951-021-01120-y","article-title":"Cargo proteins in extracellular vesicles: potential for novel therapeutics in non-alcoholic steatohepatitis","volume":"19","author":"Kim","year":"2021","journal-title":"J Nanobiotechnology"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2022.09.011","article-title":"The hepatocyte in the innate immunity","volume":"576","author":"Zhang","year":"2022","journal-title":"Virology"},{"key":"B91","doi-asserted-by":"publisher","first-page":"101244","DOI":"10.1016\/j.molmet.2021.101244","article-title":"Hepatocyte miR-34a is a key regulator in the development and progression of non-alcoholic fatty liver disease","volume":"51","author":"Xu","year":"2021","journal-title":"Mol Metab"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31050","article-title":"Lipotoxic hepatocyte-derived exosomal microRNA 192-5p activates macrophages through rictor\/akt\/forkhead box transcription factor O1 signaling in nonalcoholic fatty liver disease","volume":"72","author":"Liu","year":"2020","journal-title":"Hepatology"},{"key":"B93","doi-asserted-by":"publisher","first-page":"111738","DOI":"10.1016\/j.yexcr.2019.111738","article-title":"Cholesterol impairs hepatocyte lysosomal function causing M1 polarization of macrophages via exosomal miR-122-5p","volume":"387","author":"Zhao","year":"2020","journal-title":"Exp Cell Res"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1053\/j.gastro.2020.06.031","article-title":"IRE1A stimulates hepatocyte-derived extracellular vesicles that promote inflammation in mice with steatohepatitis","volume":"159","author":"Dasgupta","year":"2020","journal-title":"Gastroenterology"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02980","article-title":"Hepatocyte-derived lipotoxic extracellular vesicle sphingosine 1-phosphate induces macrophage chemotaxis","volume":"9","author":"Liao","year":"2018","journal-title":"Front Immunol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"G300","DOI":"10.1152\/ajpgi.00222.2016","article-title":"Inhibition of sphingosine 1-phosphate signaling ameliorates murine nonalcoholic steatohepatitis","volume":"312","author":"Mauer","year":"2017","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28252","article-title":"Mixed lineage kinase 3 mediates release of C-X-C motif ligand 10-bearing chemotactic extracellular vesicles from lipotoxic hepatocytes","volume":"63","author":"Ibrahim","year":"2016","journal-title":"Hepatology"},{"key":"B98","doi-asserted-by":"publisher","first-page":"28786","DOI":"10.1038\/srep28786","article-title":"CXCL10-Mediates Macrophage, but not Other Innate Immune Cells-Associated Inflammation in Murine Nonalcoholic Steatohepatitis","volume":"6","author":"Tomita","year":"2016","journal-title":"Sci Rep"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.12.037","article-title":"Lipid-induced signaling causes release of inflammatory extracellular vesicles from hepatocytes","volume":"150","author":"Hirsova","year":"2016","journal-title":"Gastroenterology"},{"key":"B100","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41419-022-04593-3","article-title":"The regulation, function, and role of lipophagy, a form of selective autophagy, in metabolic disorders","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis"},{"key":"B101","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/hep.31209","article-title":"Decreased hepatocyte autophagy leads to synergistic IL-1\u03b2 and TNF mouse liver injury and inflammation","volume":"72","author":"Shen","year":"2020","journal-title":"Hepatology"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241612823","article-title":"Production, exacerbating effect, and EV-mediated transcription of hepatic CCN2 in NASH: implications for diagnosis and therapy of NASH fibrosis","volume":"24","author":"Li","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B103","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.jcmgh.2015.07.007","article-title":"Lipid-induced hepatocyte-derived extracellular vesicles regulate hepatic stellate cell via microRNAs targeting PPAR-\u03b3","volume":"1","author":"Povero","year":"2015","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"3710","DOI":"10.1038\/s41598-017-03389-2","article-title":"Exosomes derived from palmitic acid-treated hepatocytes induce fibrotic activation of hepatic stellate cells","volume":"7","author":"Lee","year":"2017","journal-title":"Sci Rep"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2021.10.022","article-title":"Hepatocyte-derived exosomal miR-27a activates hepatic stellate cells through the inhibition of PINK1-mediated mitophagy in MAFLD","volume":"26","author":"Luo","year":"2021","journal-title":"Mol Ther Nucleic Acids"},{"key":"B106","doi-asserted-by":"publisher","first-page":"165857","DOI":"10.1016\/j.bbadis.2020.165857","article-title":"Extracellular vesicles derived from fat-laden hepatocytes undergoing chemical hypoxia promote a pro-fibrotic phenotype in hepatic stellate cells","volume":"1866","author":"Hern\u00e1ndez","year":"2020","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.07.019","article-title":"Integrin \u03b2(1)-enriched extracellular vesicles mediate monocyte adhesion and promote liver inflammation in murine NASH","volume":"71","author":"Guo","year":"2019","journal-title":"J Hepatol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2017.1356977","article-title":"Ezetimibe ameliorates steatohepatitis via AMP activated protein kinase-TFEB-mediated activation of autophagy and NLRP3 inflammasome inhibition","volume":"13","author":"Kim","year":"2017","journal-title":"Autophagy"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31031","article-title":"Interleukin-22 ameliorates neutrophil-driven nonalcoholic steatohepatitis through multiple targets","volume":"72","author":"Hwang","year":"2020","journal-title":"Hepatology"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abd1206","article-title":"Targeting epigenetically maladapted vascular niche alleviates liver fibrosis in nonalcoholic steatohepatitis","volume":"13","author":"Zhang","year":"2021","journal-title":"Sci Transl Med"},{"key":"B111","doi-asserted-by":"publisher","first-page":"12785","DOI":"10.1038\/s41598-020-69634-3","article-title":"Elafin inhibits obesity, hyperglycemia, and liver steatosis in high-fat diet-treated male mice","volume":"10","author":"Wang","year":"2020","journal-title":"Sci Rep"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29025","article-title":"Targeting the mitochondrial pyruvate carrier attenuates fibrosis in a mouse model of nonalcoholic steatohepatitis","volume":"65","author":"McCommis","year":"2017","journal-title":"Hepatology"},{"key":"B113","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41392-022-01073-0","article-title":"Trends in insulin resistance: insights into mechanisms and therapeutic strategy","volume":"7","author":"Li","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111629","article-title":"Pathophysiological molecular mechanisms of obesity: A link between MAFLD and NASH with cardiovascular diseases","volume":"22","author":"Guti\u00e9rrez-Cuevas","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B115","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1053\/j.gastro.2021.05.008","article-title":"Associations among adipose tissue immunology, inflammation, exosomes and insulin sensitivity in people with obesity and nonalcoholic fatty liver disease","volume":"161","author":"Fuchs","year":"2021","journal-title":"Gastroenterology"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1002\/oby.20847","article-title":"Effect of extracellular vesicles of human adipose tissue on insulin signaling in liver and muscle cells","volume":"22","author":"Kranendonk","year":"2014","journal-title":"Obes (Silver Spring)"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.2337\/db09-0216","article-title":"Adipose tissue exosome-like vesicles mediate activation of macrophage-induced insulin resistance","volume":"58","author":"Deng","year":"2009","journal-title":"Diabetes"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.v14.10","article-title":"LINC01705 derived from adipocyte exosomes regulates hepatocyte lipid accumulation via an miR-552-3p\/LXR axis","volume":"14","author":"Lin","year":"2023","journal-title":"J Diabetes Investig"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v29.i29.4528","article-title":"Antagonizing adipose tissue-derived exosome miR-103-hepatocyte phosphatase and tensin homolog pathway alleviates autophagy in non-alcoholic steatohepatitis: A trans-cellular crosstalk","volume":"29","author":"Lu","year":"2023","journal-title":"World J Gastroenterol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"E579","DOI":"10.1152\/ajpendo.00172.2020","article-title":"Aerobic exercise training regulates serum extracellular vesicle miRNAs linked to obesity to promote their beneficial effects in mice","volume":"319","author":"de Mendon\u00e7a","year":"2020","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.2337\/db11-1297","article-title":"Depressed levels of prostaglandin F2\u03b1 in mice lacking Akr1b7 increase basal adiposity and predispose to diet-induced obesity","volume":"61","author":"Volat","year":"2012","journal-title":"Diabetes"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2020.12.011","article-title":"ER stress-induced adipocytes secrete-aldo-keto reductase 1B7-containing exosomes that cause nonalcoholic steatohepatitis in mice","volume":"163","author":"Gu","year":"2021","journal-title":"Free Radic Biol Med"},{"key":"B123","doi-asserted-by":"publisher","first-page":"e12561","DOI":"10.1111\/jpi.2019.66.issue-4","article-title":"Reduced delivery of epididymal adipocyte-derived exosomal resistin is essential for melatonin ameliorating hepatic steatosis in mice","volume":"66","author":"Rong","year":"2019","journal-title":"J Pineal Res"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2014.06.050","article-title":"Adipocyte exosomes induce transforming growth factor beta pathway dysregulation in hepatocytes: a novel paradigm for obesity-related liver disease","volume":"192","author":"Koeck","year":"2014","journal-title":"J Surg Res"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2022.09.017","article-title":"Gut-liver axis: Pathophysiological concepts and clinical implications","volume":"34","author":"Tilg","year":"2022","journal-title":"Cell Metab"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-020-00814-7","article-title":"The role of the gut microbiome and its metabolites in metabolic diseases","volume":"12","author":"Wu","year":"2021","journal-title":"Protein Cell"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27489","article-title":"Dysbiosis-induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice","volume":"61","author":"Chen","year":"2015","journal-title":"Hepatology"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: Pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J Hepatol"},{"key":"B129","doi-asserted-by":"publisher","first-page":"e12395","DOI":"10.1002\/jev2.v12.12","article-title":"Single-particle analysis of circulating bacterial extracellular vesicles reveals their biogenesis, changes in blood and links to intestinal barrier","volume":"12","author":"Ou","year":"2023","journal-title":"J Extracell Vesicles"},{"key":"B130","doi-asserted-by":"publisher","first-page":"e12303","DOI":"10.1002\/jev2.12303","article-title":"Faeces-derived extracellular vesicles participate in the onset of barrier dysfunction leading to liver diseases","volume":"12","author":"Fizanne","year":"2023","journal-title":"J Extracell Vesicles"},{"key":"B131","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41467-020-20500-w","article-title":"High-fat diet-induced upregulation of exosomal phosphatidylcholine contributes to insulin resistance","volume":"12","author":"Kumar","year":"2021","journal-title":"Nat Commun"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23999","article-title":"Human T cell microparticles circulate in blood of hepatitis patients and induce fibrolytic activation of hepatic stellate cells","volume":"53","author":"Kornek","year":"2011","journal-title":"Hepatology"},{"key":"B133","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.cell.2017.08.035","article-title":"Adipose tissue macrophage-derived exosomal miRNAs can modulate in vivo and in vitro insulin sensitivity","volume":"171","author":"Ying","year":"2017","journal-title":"Cell"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5320(67)80128-X","article-title":"Ultrastructural changes during growth and embryogenesis in carrot cell cultures","volume":"18","author":"Halperin","year":"1967","journal-title":"J Ultrastruct Res"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jafc.3c06867","article-title":"Plant-derived extracellular vesicles: A new revolutionization of modern healthy diets and biomedical applications","volume":"72","author":"Lo","year":"2024","journal-title":"J Agric Food Chem"},{"key":"B136","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ymthe.2020.11.030","article-title":"Plant exosome-like nanovesicles: emerging therapeutics and drug delivery nanoplatforms","volume":"29","author":"Dad","year":"2021","journal-title":"Mol Ther"},{"key":"B137","doi-asserted-by":"publisher","first-page":"e12283","DOI":"10.1002\/jev2.v11.12","article-title":"Plant-derived extracellular vesicles: Recent advancements and current challenges on their use for biomedical applications","volume":"11","author":"Lian","year":"2022","journal-title":"J Extracell Vesicles"},{"key":"B138","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ajps.2021.05.006","article-title":"Plant-derived exosome-like nanoparticles and their therapeutic activities","volume":"17","author":"Kim","year":"2022","journal-title":"Asian J Pharm Sci"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-021-00681-w","article-title":"Blueberry-derived exosomes-like nanoparticles ameliorate nonalcoholic fatty liver disease by attenuating mitochondrial oxidative stress","volume":"43","author":"Zhao","year":"2022","journal-title":"Acta Pharmacol Sin"},{"key":"B140","doi-asserted-by":"publisher","first-page":"154679","DOI":"10.1016\/j.phymed.2023.154679","article-title":"Garlic-derived exosomes regulate PFKFB3 expression to relieve liver dysfunction in high-fat diet-fed mice via macrophage-hepatocyte crosstalk","volume":"112","author":"Liu","year":"2023","journal-title":"Phytomedicine"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2020.08.009","article-title":"Use of nanovesicles from orange juice to reverse diet-induced gut modifications in diet-induced obese mice","volume":"18","author":"Berger","year":"2020","journal-title":"Mol Ther Methods Clin Dev"},{"key":"B142","doi-asserted-by":"publisher","first-page":"e2105738","DOI":"10.1002\/adma.202105738","article-title":"Metal-organic-framework-based hydrogen-release platform for multieffective helicobacter pylori targeting therapy and intestinal flora protective capabilities","volume":"34","author":"Zhang","year":"2022","journal-title":"Adv Mater"},{"key":"B143","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000489737","article-title":"Hydrogen therapy in cardiovascular and metabolic diseases: from bench to bedside","volume":"47","author":"Zhang","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"B144","doi-asserted-by":"publisher","first-page":"121030","DOI":"10.1016\/j.biomaterials.2021.121030","article-title":"Nanocapsule-mediated sustained H(2) release in the gut ameliorates metabolic dysfunction-associated fatty liver disease","volume":"276","author":"Jin","year":"2021","journal-title":"Biomaterials"},{"key":"B145","doi-asserted-by":"publisher","first-page":"122804","DOI":"10.1016\/j.biomaterials.2024.122804","article-title":"Biomimetic nanoplatform with microbiome modulation and antioxidant functions ameliorating insulin resistance and pancreatic \u03b2-cell dysfunction for T2DM management","volume":"313","author":"Wang","year":"2024","journal-title":"Biomaterials"},{"key":"B146","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41579-020-0433-9","article-title":"Gut microbiota in human metabolic health and disease","volume":"19","author":"Fan","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-326789","article-title":"Gut microbiome and health: mechanistic insights","volume":"71","author":"de Vos","year":"2022","journal-title":"Gut"},{"key":"B148","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41579-020-0438-4","article-title":"Gut microbial metabolites as multi-kingdom intermediates","volume":"19","author":"Krautkramer","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28829","article-title":"Changes in blood microbiota profiles associated with liver fibrosis in obese patients: A pilot analysis","volume":"64","author":"Lelouvier","year":"2016","journal-title":"Hepatology"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1002\/emmm.201100159","article-title":"Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment","volume":"3","author":"Amar","year":"2011","journal-title":"EMBO Mol Med"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-4483","article-title":"Bacterial DNA translocation holds increased insulin resistance and systemic inflammatory levels in morbid obese patients","volume":"99","author":"Ortiz","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.10.042","article-title":"CRIg(+) macrophages prevent gut microbial DNA-containing extracellular vesicle-induced tissue inflammation and insulin resistance","volume":"160","author":"Luo","year":"2021","journal-title":"Gastroenterology"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1966.tb52382.x","article-title":"The chemistry and electron microscopy of an extracellular lipopolysaccharide from Escherichia coli","volume":"133","author":"Work","year":"1966","journal-title":"Ann N Y Acad Sci"},{"key":"B154","doi-asserted-by":"publisher","first-page":"e450","DOI":"10.1038\/emm.2017.282","article-title":"Akkermansia muciniphila-derived extracellular vesicles influence gut permeability through the regulation of tight junctions","volume":"50","author":"Chelakkot","year":"2018","journal-title":"Exp Mol Med"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.01502","article-title":"Gram-positive bacterial extracellular vesicles and their impact on health and disease","volume":"9","author":"Liu","year":"2018","journal-title":"Front Microbiol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.5507\/bp.2021.042","article-title":"Extracellular vesicles derived from gut microbiota in inflammatory bowel disease and colorectal cancer","volume":"165","author":"Alberti","year":"2021","journal-title":"BioMed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"B157","doi-asserted-by":"publisher","first-page":"e108174","DOI":"10.15252\/embj.2021108174","article-title":"The extracellular vesicle generation paradox: a bacterial point of view","volume":"40","author":"McMillan","year":"2021","journal-title":"EMBO J"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v13.i11.1732","article-title":"Increased intestinal permeability in pathogenesis and progress of nonalcoholic steatohepatitis in rats","volume":"13","author":"Jin","year":"2007","journal-title":"World J Gastroenterol"},{"key":"B160","doi-asserted-by":"publisher","first-page":"15878","DOI":"10.1038\/srep15878","article-title":"Gut microbe-derived extracellular vesicles induce insulin resistance, thereby impairing glucose metabolism in skeletal muscle","volume":"5","author":"Choi","year":"2015","journal-title":"Sci Rep"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-023-00771-6","article-title":"Gut-liver axis: barriers and functional circuits","volume":"20","author":"Pabst","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B162","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41467-022-28239-2","article-title":"Accumulation of microbial DNAs promotes to islet inflammation and \u03b2 cell abnormalities in obesity in mice","volume":"13","author":"Gao","year":"2022","journal-title":"Nat Commun"},{"key":"B163","doi-asserted-by":"publisher","first-page":"e13827","DOI":"10.1111\/apha.v235.3","article-title":"Microbial DNA enrichment promotes liver steatosis and fibrosis in the course of non-alcoholic steatohepatitis","volume":"235","author":"Luo","year":"2022","journal-title":"Acta Physiol (Oxf)"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2018.12.180","article-title":"Gut dysbiosis-derived exosomes trigger hepatic steatosis by transiting HMGB1 from intestinal to liver in mice","volume":"509","author":"Chen","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24552","article-title":"Nuclear factor high-mobility group box1 mediating the activation of Toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice","volume":"54","author":"Li","year":"2011","journal-title":"Hepatology"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-022-00631-9","article-title":"Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms","volume":"19","author":"Cani","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B167","doi-asserted-by":"publisher","first-page":"e0048421","DOI":"10.1128\/Spectrum.00484-21","article-title":"The Protective Effects of Live and Pasteurized Akkermansia muciniphila and Its Extracellular Vesicles against HFD\/CCl4-Induced Liver Injury","volume":"9","author":"Keshavarz Azizi Raftar","year":"2021","journal-title":"Microbiol Spectr"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1196831","article-title":"Role of extracellular vesicles in nonalcoholic fatty liver disease","volume":"14","author":"Jiang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-99-1443-2_9","article-title":"Extracellular vesicles and fatty liver","volume":"1418","author":"Lu","year":"2023","journal-title":"Adv Exp Med Biol"},{"key":"B170","doi-asserted-by":"publisher","first-page":"4","DOI":"10.37349\/edd","article-title":"Extracellular vesicles in metabolic dysfunction associated fatty liver disease: mechanisms, diagnostic and therapeutic implications","volume":"1","author":"Wu","year":"2022","journal-title":"Explor Digestive Diseases"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2024.03.009","article-title":"The role of extracellular vesicles in non-alcoholic steatohepatitis: Emerging mechanisms, potential therapeutics and biomarkers","author":"Wang","year":"2024","journal-title":"J Adv Res"},{"key":"B172","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12951-023-01921-3","article-title":"Extracellular vesicles: emerging roles, biomarkers and therapeutic strategies in fibrotic diseases","volume":"21","author":"Zhu","year":"2023","journal-title":"J Nanobiotechnology"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713326","article-title":"Comprehensive strategy for identifying extracellular vesicle surface proteins as biomarkers for non-alcoholic fatty liver disease","volume":"24","author":"Garcia","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B174","doi-asserted-by":"publisher","first-page":"e1800180","DOI":"10.1002\/pmic.201800180","article-title":"Breast cancer-derived exosomes reflect the cell-of-origin phenotype","volume":"19","author":"Wen","year":"2019","journal-title":"Proteomics"},{"key":"B175","doi-asserted-by":"publisher","first-page":"e12454","DOI":"10.1002\/jev2.12454","article-title":"A novel multi-stage enrichment workflow and comprehensive characterization for HEK293F-derived extracellular vesicles","volume":"13","author":"Vo","year":"2024","journal-title":"J Extracell Vesicles"},{"key":"B176","doi-asserted-by":"publisher","first-page":"e70005","DOI":"10.1002\/jev2.v13.12","article-title":"Extracellular vesicles, RNA sequencing, and bioinformatic analyses: Challenges, solutions, and recommendations","volume":"13","author":"Miceli","year":"2024","journal-title":"J Extracell Vesicles"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231810522","article-title":"Methods of the large-scale production of extracellular vesicles","volume":"23","author":"Syromiatnikova","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.4c00666","article-title":"A panorama of extracellular vesicle applications: from biomarker detection to therapeutics","volume":"18","author":"Das","year":"2024","journal-title":"ACS Nano"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1544012\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T01:15:30Z","timestamp":1741569330000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1544012\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,10]]},"references-count":178,"alternative-id":["10.3389\/fimmu.2025.1544012"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1544012","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,10]]},"article-number":"1544012"}}